Looking at some ROIC (Return on Invested Capital) numbers, Hans Biomed Corporation (KOSDAQ:A042520)’s ROIC Quality Score is 1.933775. ROIC is a profitability ratio that measures the return that an investment generates for those providing capital. ROIC helps show how efficient a firm is at turning capital into profits. This formula is calculated by 5 year average Return on Invested Capital (ROIC) / Standard Deviation of the 5 year ROIC. The higher the ratio, the better as a higher score indicates a more stable return on invested capital.

We can now take a quick look at some historical stock price index data. Hans Biomed Corporation (KOSDAQ:A042520) presently has a 10 month price index of 0.91944. The price index is calculated by dividing the current share price by the share price ten months ago. A ratio over one indicates an increase in share price over the period. A ratio lower than one shows that the price has decreased over that time period. Looking at some alternate time periods, the 12 month price index is 0.84655, the 24 month is 0.71306, and the 36 month is 1.17958. Narrowing in a bit closer, the 5 month price index is 1.02812, the 3 month is 0.96765, and the 1 month is currently 0.89160.

**Ratios**

Hans Biomed Corporation (KOSDAQ:A042520) has a Price to Book ratio of 2.911152. This ratio is calculated by dividing the current share price by the book value per share. Investors may use Price to Book to display how the market portrays the value of a stock. Checking in on some other ratios, the company has a Price to Cash Flow ratio of 29.374084, and a current Price to Earnings ratio of 21.787554. The P/E ratio is one of the most common ratios used for figuring out whether a company is overvalued or undervalued.

Checking in on some valuation rankings, Hans Biomed Corporation (KOSDAQ:A042520) has a Value Composite score of 56. Developed by James O’Shaughnessy, the VC score uses five valuation ratios. These ratios are price to earnings, price to cash flow, EBITDA to EV, price to book value, and price to sales. The VC is displayed as a number between 1 and 100. In general, a company with a score closer to 0 would be seen as undervalued, and a score closer to 100 would indicate an overvalued company. Adding a sixth ratio, shareholder yield, we can view the Value Composite 2 score which is currently sitting at 55.

Watching some historical volatility numbers on shares of Hans Biomed Corporation (KOSDAQ:A042520), we can see that the 12 month volatility is presently 24.014400. The 6 month volatility is 26.727600, and the 3 month is spotted at 21.524000. Following volatility data can help measure how much the stock price has fluctuated over the specified time period. Although past volatility action may help project future stock volatility, it may also be vastly different when taking into account other factors that may be driving price action during the measured time period.

**Score**

The Gross Margin Score is calculated by looking at the Gross Margin and the overall stability of the company over the course of 8 years. The score is a number between one and one hundred (1 being best and 100 being the worst). The Gross Margin Score of Hans Biomed Corporation (KOSDAQ:A042520) is 20.00000. The more stable the company, the lower the score. If a company is less stable over the course of time, they will have a higher score.